CARE:CA:TSX-Dialogue Health Technologies Inc (CAD)

COMMON STOCK | Health Information Services | TSX

Last Closing Price

CAD 5.95

Change

-0.05 (-0.83)%

Market Cap

CAD 0.39B

Volume

0.03M

Avg Analyst Target

CAD 13.38 (+124.79%)

Avg User Target

CAD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Dialogue Health Technologies Inc (CARE) Stock Analysis:
Based on the Dialogue Health Technologies Inc stock forecasts from 6 analysts, the average analyst target price for Dialogue Health Technologies Inc is CAD 13.38 over the next 12 months. Dialogue Health Technologies Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Dialogue Health Technologies Inc is Slightly Bullish , which is based on 2 positive signals and 1 negative signals. At the last closing, Dialogue Health Technologies Inc’s stock price was CAD 5.95. Dialogue Health Technologies Inc’s stock price has changed by -0.41% over the past week, -0.44% over the past month and +0.00% over the last year.

About

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada. Its Integrated Health Platform is a healthcare hub that provides access to virtual healthcare, stress management, mental wellbeing, and other orientation and counselling services. The ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-19 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
KSI:CA Kneat.com Inc

-0.06 (-1.88%)

CAD0.25B N/A N/A
VHI:CA Vitalhub Corp

-0.05 (-1.67%)

CAD0.11B N/A 198.37
MBCN:CA MindBeacon Holdings Inc

N/A

CAD0.08B N/A N/A

ETFs Containing CARE:CA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -18.38% 67% D+ 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -18.38% 67% D+ 2% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.39B 100% A+ 52% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 3.96 67% D+ 20% F
Price / Cash Flow Ratio -21.43 67% D+ 90% A-
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -9,999,999.00% 33% F 0% N/A
Return on Invested Capital 117.65% 100% A+ 99% A+
Return on Assets -24.63% 33% F 5% F
Debt to Equity Ratio -4.67% 100% A+ 96% A
Technical Ratios  
Short Ratio 1.77 33% F 47% F
Short Percent 0.18% 50% F 79% C+
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.